Danielle Brill
Stock Analyst at Truist Financial
(4.60)
# 950
Out of 5,119 analysts
419
Total ratings
52.4%
Success rate
10.3%
Average return
Main Sectors:
Stocks Rated by Danielle Brill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLYM Climb Bio | Reiterated: Buy | $25 | $10.29 | +142.95% | 9 | Nov 6, 2026 | |
| IRON Disc Medicine | Reiterated: Buy | $115 | $78.91 | +45.74% | 24 | Nov 6, 2026 | |
| PVLA Palvella Therapeutics | Reiterated: Buy | $207 | $175.92 | +17.67% | 14 | Nov 6, 2026 | |
| ALNY Alnylam Pharmaceuticals | Downgraded: Hold | $225 | $155.94 | +44.29% | 20 | Nov 2, 2026 | |
| BIIB Biogen | Reiterated: Buy | $235 → $260 | $248.35 | +4.69% | 20 | Oct 29, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | n/a | $3.37 | - | 4 | Oct 2, 2026 | |
| IMVT Immunovant | Reiterated: Hold | n/a | $30.53 | - | 16 | Sep 24, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | n/a | $24.44 | - | 5 | Sep 23, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | n/a | $547.09 | - | 11 | Sep 23, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $64 | $34.19 | +87.19% | 6 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $6.59 | +203.49% | 1 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,030 → $1,095 | $927.21 | +18.10% | 34 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $102 → $107 | $74.29 | +44.03% | 15 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $25 | $3.23 | +673.99% | 7 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 | $114.41 | +70.45% | 10 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $20.64 | +190.70% | 12 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $616 | $277.62 | +121.89% | 3 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $128 | $86.03 | +48.79% | 9 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $29 → $34 | $33.11 | +2.69% | 20 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $213 | $164.63 | +29.38% | 24 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $9.09 | $21.70 | n/a | 23 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $7.62 | n/a | 3 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $21.23 | n/a | 19 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $29.41 | n/a | 3 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $79 | $56.03 | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $20.07 | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $65.44 | n/a | 21 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $150 | $17.82 | n/a | 36 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 → $50 | $39.17 | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.73 | n/a | 19 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $10 | $3.98 | n/a | 5 | May 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $17.08 | n/a | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $45 | $9.36 | n/a | 2 | May 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $45.90 | n/a | 10 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $132.37 | n/a | 1 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $13.54 | n/a | 5 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $166.89 | n/a | 1 | Jul 26, 2016 |
Climb Bio
Nov 6, 2026
Reiterated: Buy
Price Target: $25
Current: $10.29
Upside: +142.95%
Disc Medicine
Nov 6, 2026
Reiterated: Buy
Price Target: $115
Current: $78.91
Upside: +45.74%
Palvella Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $207
Current: $175.92
Upside: +17.67%
Alnylam Pharmaceuticals
Nov 2, 2026
Downgraded: Hold
Price Target: $225
Current: $155.94
Upside: +44.29%
Biogen
Oct 29, 2026
Reiterated: Buy
Price Target: $235 → $260
Current: $248.35
Upside: +4.69%
Wave Life Sciences
Oct 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.37
Upside: -
Immunovant
Sep 24, 2026
Reiterated: Hold
Price Target: n/a
Current: $30.53
Upside: -
Rapport Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $24.44
Upside: -
Vertex Pharmaceuticals
Sep 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $547.09
Upside: -
Maze Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: $64
Current: $34.19
Upside: +87.19%
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $6.59
Upside: +203.49%
Aug 18, 2026
Reiterated: Buy
Price Target: $1,030 → $1,095
Current: $927.21
Upside: +18.10%
Aug 12, 2026
Reiterated: Buy
Price Target: $102 → $107
Current: $74.29
Upside: +44.03%
Aug 12, 2026
Reiterated: Buy
Price Target: $43 → $25
Current: $3.23
Upside: +673.99%
Aug 10, 2026
Reiterated: Buy
Price Target: $195
Current: $114.41
Upside: +70.45%
Aug 10, 2026
Reiterated: Buy
Price Target: $60
Current: $20.64
Upside: +190.70%
Aug 7, 2026
Reiterated: Buy
Price Target: $616
Current: $277.62
Upside: +121.89%
Aug 6, 2026
Reiterated: Buy
Price Target: $128
Current: $86.03
Upside: +48.79%
Aug 5, 2026
Reiterated: Hold
Price Target: $29 → $34
Current: $33.11
Upside: +2.69%
Aug 3, 2026
Reiterated: Buy
Price Target: $200 → $213
Current: $164.63
Upside: +29.38%
Dec 10, 2024
Reiterated: Buy
Price Target: $20 → $9.09
Current: $21.70
Upside: n/a
Nov 18, 2024
Reiterated: Buy
Price Target: $18
Current: $7.62
Upside: n/a
Oct 10, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $21.23
Upside: n/a
Oct 10, 2024
Initiated Coverage: Buy
Price Target: $51
Current: $29.41
Upside: n/a
Oct 10, 2024
Initiated Coverage: Buy
Price Target: $79
Current: $56.03
Upside: n/a
Oct 10, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $20.07
Upside: n/a
Oct 10, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $65.44
Upside: n/a
Oct 10, 2024
Initiated Coverage: Buy
Price Target: $150
Current: $17.82
Upside: n/a
Oct 10, 2024
Initiated Coverage: Buy
Price Target: $52 → $50
Current: $39.17
Upside: n/a
Jun 26, 2023
Downgraded: Hold
Price Target: n/a
Current: $3.73
Upside: n/a
May 16, 2022
Reiterated: Buy
Price Target: $24 → $10
Current: $3.98
Upside: n/a
Jun 30, 2021
Initiated Coverage: Hold
Price Target: n/a
Current: $17.08
Upside: n/a
May 27, 2020
Reiterated: Buy
Price Target: $35 → $45
Current: $9.36
Upside: n/a
Feb 13, 2020
Reiterated: Hold
Price Target: n/a
Current: $45.90
Upside: n/a
Dec 16, 2019
Reiterated: Buy
Price Target: $125
Current: $132.37
Upside: n/a
Nov 7, 2019
Reiterated: Hold
Price Target: $6 → $5
Current: $13.54
Upside: n/a
Jul 26, 2016
Downgraded: Hold
Price Target: n/a
Current: $166.89
Upside: n/a